X-129487094-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001282874.2(SMARCA1):āc.2141C>Gā(p.Ser714Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000436 in 1,168,580 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.000018 ( 0 hom., 2 hem., cov: 23)
Exomes š: 0.000046 ( 0 hom. 20 hem. )
Consequence
SMARCA1
NM_001282874.2 missense
NM_001282874.2 missense
Scores
7
7
3
Clinical Significance
Conservation
PhyloP100: 9.17
Genes affected
SMARCA1 (HGNC:11097): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1) This gene encodes a member of the SWI/SNF family of proteins. The encoded protein is an ATPase which is expressed in diverse tissues and contributes to the chromatin remodeling complex that is involved in transcription. The protein may also play a role in DNA damage, growth inhibition and apoptosis of cancer cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA1 | NM_001282874.2 | c.2141C>G | p.Ser714Cys | missense_variant | 17/25 | ENST00000371121.5 | NP_001269803.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA1 | ENST00000371121.5 | c.2141C>G | p.Ser714Cys | missense_variant | 17/25 | 1 | NM_001282874.2 | ENSP00000360162.4 | ||
SMARCA1 | ENST00000371123.5 | c.2105C>G | p.Ser702Cys | missense_variant | 16/24 | 1 | ENSP00000360164.2 | |||
SMARCA1 | ENST00000371122.8 | c.2141C>G | p.Ser714Cys | missense_variant | 17/25 | 1 | ENSP00000360163.4 | |||
SMARCA1 | ENST00000617310.4 | n.2199C>G | non_coding_transcript_exon_variant | 16/23 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111682Hom.: 0 Cov.: 23 AF XY: 0.0000590 AC XY: 2AN XY: 33888
GnomAD3 genomes
AF:
AC:
2
AN:
111682
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33888
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000117 AC: 2AN: 170299Hom.: 0 AF XY: 0.0000178 AC XY: 1AN XY: 56285
GnomAD3 exomes
AF:
AC:
2
AN:
170299
Hom.:
AF XY:
AC XY:
1
AN XY:
56285
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000464 AC: 49AN: 1056844Hom.: 0 Cov.: 21 AF XY: 0.0000611 AC XY: 20AN XY: 327324
GnomAD4 exome
AF:
AC:
49
AN:
1056844
Hom.:
Cov.:
21
AF XY:
AC XY:
20
AN XY:
327324
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111736Hom.: 0 Cov.: 23 AF XY: 0.0000589 AC XY: 2AN XY: 33952
GnomAD4 genome
AF:
AC:
2
AN:
111736
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33952
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.2141C>G (p.S714C) alteration is located in exon 17 (coding exon 17) of the SMARCA1 gene. This alteration results from a C to G substitution at nucleotide position 2141, causing the serine (S) at amino acid position 714 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.
REVEL
Pathogenic
Sift
Uncertain
D;D;.
Sift4G
Uncertain
D;D;D
Polyphen
D;.;D
Vest4
MutPred
Loss of phosphorylation at S714 (P = 0.0146);.;Loss of phosphorylation at S714 (P = 0.0146);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at